{"SLR NAME":"COVID-19 in pregnancy: systematic review and meta-analysis of larger case series","References":[{"title1":"Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients","References":[{"title2":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) in Mexico"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada"},{"title3":"KDIGO clinical practice guideline for acute kidney injury"},{"title3":"Wuhan: Britons to be evacuated as scientists estimate 44 000 cases of 2019-nCOV in the city"},{"title3":"Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome"},{"title3":"Short-term outcome of critically ill patients with severe acute respiratory syndrome"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries"},{"title3":"China built a hospital in 10 days to battle coronavirus"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Asymptomatic cases complicate efforts"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV"},{"title3":"Practice of diagnosis and management of acute respiratory distress syndrome in mainland China: a cross-sectional study"},{"title3":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury"}]},{"title2":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","References":[]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from URL: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) (accessed February 2020)."},{"title3":"Government of Canada. Government of Canada evacuating Canadians from Wuhan, China. Available from URL: https://www.canada.ca/en/global-affairs/news/2020/02/government-of-canada-evacuating-canadians-from-wuhan-china.html (accessed February 2020)."},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Evidence of airborne transmission of the severe acute respiratory syndrome virus"},{"title3":"Illness in intensive care staff after brief exposure to severe acute respiratory syndrome"},{"title3":"Febrile respiratory illness in the intensive care unit setting: an infection control perspective"},{"title3":"Critically ill patients with severe acute respiratory syndrome"},{"title3":"Possible SARS coronavirus transmission during cardiopulmonary resuscitation"},{"title3":"Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 2020; DOI: 10.1016/j.ijid.2020.01.050."},{"title3":"World Health Organization. Novel Coronavirus (2019-nCoV). WHO Bull 2020 - Data as reported by January 30, 2020. Available from URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2 (accessed February 2020)."},{"title3":"Severe acute respiratory syndrome"},{"title3":"Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-coronavirus reproductive number and case fatality rate for the Spring 2014 Saudi Arabia outbreak: insights from publicly available data. PLoS Curr 2014. Available from URL: http://currents.plos.org/outbreaks/index.html%3Fp=40801.html (accessed February 2020)."},{"title3":"Donaldson LJ, Rutter PD, Ellis BM, et al. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2010; DOI:10.1136/bmj.b5213 (accessed February 2020)."},{"title3":"World Health Organization. Novel coronavirus (nCoV 2019) situation as of 07 February 2020, 10:00 (CET). Available from URL: http://who.maps.arcgis.com/apps/opsdashboard/index.html#/c88e37cfc43b4ed3baf977d77e4a0667 (accessed February 2020)."},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"Kupferschmidt K. Study claiming new coronavirus can be transmitted by people without symptoms was flawed. Science (February 3, 2020). Available from URL: https://www.sciencemag.org/news/2020/02/paper-non-symptomatic-patient-transmitting-coronavirus-wrong (accessed February 2020)."},{"title3":"Potential for global spread of a novel coronavirus from China"},{"title3":"China's response to a novel coronavirus stands in stark contrast to the 2002 SARS outbreak response"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Brest M. Wuhan doctor treating coronavirus patients dies after contracting disease. Washington Examiner. Available from URL: https://www.washingtonexaminer.com/news/wuhan-doctor-treating-coronavirus-patients-dies-after-contracting-disease (accessed February 2020)."},{"title3":"Buckley C. Chinese Doctor, Silenced After Warning of Outbreak, Dies From Coronavirus. The New York Times. Available from URL: https://www.nytimes.com/2020/02/06/world/asia/chinese-doctor-Li-Wenliang-coronavirus.html (accessed February 2020)."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Government of Canada. Interim national case definition: novel coronavirus (2019-nCoV). Available from URL: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/national-case-definition.html (accessed February 2020)."},{"title3":"SARS in healthcare facilities, Toronto and Taiwan"},{"title3":"Government of Canada. Infection prevention and control for novel coronavirus (2019-nCoV): interim guidance for acute healthcare settings. Available from URL: https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/interim-guidance-acute-healthcare-settings.html (accessed Februay 2020)."},{"title3":"XINHUANET. Novel coronavirus may spread via digestive system: experts. | English.news.cn. Available from URL: http://www.xinhuanet.com/english/2020-02/02/c_138749620.htm (accessed February 2020)."},{"title3":"Role of air distribution in SARS transmission during the largest nosocomial outbreak in Hong Kong"},{"title3":"Hospital preparedness and SARS"},{"title3":"Novak D. Why, where, and how PAPRs are being used in health care. In: Institute of Medicine. The Use and Effectiveness of Powered Air Purifying Respirators in Health Care: Workshop Summary - 2015. Washington, DC: The National Academies Press. Available from URL: https://www.ncbi.nlm.nih.gov/books/NBK294225/#_NBK294225_pubdet (accessed February 2020)."},{"title3":"Contamination: a comparison of 2 personal protective systems"},{"title3":"Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial"},{"title3":"Effectiveness of noninvasive positive pressure ventilation in the treatment of acute respiratory failure in severe acute respiratory syndrome"},{"title3":"Ultrasound for airway management: an evidence-based review for the emergency clinician"},{"title3":"Acute respiratory distress syndrome: advances in diagnosis and treatment"},{"title3":"Elective and emergency surgery in patients with severe acute respiratory syndrome (SARS)"},{"title3":"Safety of Patients Isolated for Infection Control"},{"title3":"Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome"}]},{"title2":"Chest computed tomography images of early coronavirus disease (COVID-19)","References":[{"title3":"World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 48. Available from URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200308-sitrep-48-covid-19.pdf?sfvrsn=16f7ccef_4 (accessed March 2020)."},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Coronavirus Disease 2019 (COVID-19): Role of chest CT in diagnosis and management"}]},{"title2":"A major outbreak of severe acute respiratory syndrome in Hong Kong","References":[]},{"title2":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","References":[{"title3":"Severe respiratory illness associated with a novel coronavirus: Saudi Arabia and Qatar, 2012"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Global alert and response (GAR): novel coronavirus summary and literature update"},{"title3":"Global alert and response (GAR): novel coronavirus infection:update (Middle East respiratory syndrome coronavirus)"},{"title3":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV):worldwide, 2012-2013"},{"title3":"Rapid risk assessment: update:severe respiratory disease associated with a novel coronavirus"},{"title3":"Epidemiological update: additional confirmed cases of Middle East respiratory syndrome coronavirus (novel coronavirus) in France, Saudi Arabia, and Tunisia"},{"title3":"Table: confirmed cases of Middle East coronavirus infection reported in Europe (n=11 of 53 cases reported worldwide)"},{"title3":"Recovery from severe novel coronavirus infection"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Hospital outbreak of Middle East respiratory syndrome coronavirus"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012"},{"title3":"Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013"},{"title3":"First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013"},{"title3":"Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission"},{"title3":"Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction"},{"title3":"Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections"},{"title3":"Global alert and response (GAR): Middle East respiratory syndrome coronavirus (MERS-CoV):update"},{"title3":"Prevalence of diabetes mellitus in a Saudi community"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Severe acute respiratory syndrome and coronavirus"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical and laboratory features in the early stage of severe acute respiratory syndrome"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Features discriminating SARS from other severe viral respiratory tract infections"},{"title3":"Clinical and laboratory features of severe acute respiratory syndrome vis-a-vis onset of fever"},{"title3":"Severe acute respiratory syndrome"},{"title3":"Assessing the pandemic potential of MERS-CoV"},{"title3":"Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart"},{"title3":"Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk"},{"title3":"Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak"},{"title3":"Rapid diagnostics urgently needed for killer infections"},{"title3":"Laboratory capability for molecular detection and confirmation of novel coronavirus in Europe, November 2012"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"Vertical transmission of human coronavirus. Prospective pilot study (French)","References":[]},{"title2":"ACE2 expression in kidney and testis may cause kidney and testis damage after 2019-nCoV infection","References":[]},{"title2":"Obstetric anesthesia: leading the way in patient safety","References":[]},{"title2":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","References":[]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]}]},{"title1":"Association of COVID-19 with pregnancy outcomes in health-care workers and general women","References":[{"title2":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","References":[{"title3":"Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome)"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Coronaviridae"},{"title3":"Another decade, another coronavirus"},{"title3":"Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wuhan Seafood Market May Not Be Source of Novel Virus Spreading Globally"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"title3":"Novel Coronavirus (2019-nCoV). Situation Report-20"},{"title3":"W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Risk factors associated with the increasing prevalence of pneumonia during pregnancy"},{"title3":"Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome?"},{"title3":"Indirect obstetric deaths in the state of Michigan 1960-1968"},{"title3":"Pneumonia during pregnancy"},{"title3":"Emerging infections and pregnancy"},{"title3":"Immunobiologic adaptations of pregnancy"},{"title3":"Acute respiratory failure in pregnancy due to staphylococcal pneumonia"},{"title3":"Pregnancy and the lung"},{"title3":"Influenza occurring in pregnant women; a statistical study of thirteen hundred and fifty cases"},{"title3":"Observations on excess mortality associated with epidemic influenza"},{"title3":"Learning from SARS: Renewal of Public Health in Canada:SARS in Canada: Anatomy of an Outbreak"},{"title3":"Reporting Incidence of Severe Acute Respiratory Syndrome (SARS) Appendix A: Chronology"},{"title3":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and pregnancy"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Infection control for SARS in a tertiary neonatal centre"},{"title3":"SARS in newborns and children"},{"title3":"No. 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome"},{"title3":"Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome"},{"title3":"SARS and pregnancy: A case report"},{"title3":"SARS in pregnancy"},{"title3":"SARS during pregnancy, United States"},{"title3":"Severe acute respiratory syndrome in pregnancy"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children"},{"title3":"The placentas of patients with severe acute respiratory syndrome: A pathophysiological evaluation"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome"},{"title3":"The SARS epidemic in Hong Kong: What lessons have we learned?"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"Middle East Respiratory Syndrome (MERS) Background"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: A report of 5 cases from Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome (MERS) Fact Sheet"},{"title3":"MERS-CoV infection in pregnant woman in Korea"},{"title3":"Middle East Respiratory Syndrome (MERS) Overview"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East respiratory syndrome: What we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"An Overview of the latest infectious diseases around the world"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates 2013"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of literature"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Vertical transmission of human coronavirus. Prospective pilot study"},{"title3":"Materno-fetal transmission of human coronaviruses: A prospective pilot study"},{"title3":"Emerging respiratory viruses: Challenges and vaccine strategies"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Clinical trials and administration of Zika virus vaccine in pregnant women: Lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation"},{"title3":"Being pregnant during the Kivu Ebola virus outbreak in DR Congo: The rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas"},{"title3":"Maternal and infant death and the rVSV-ZEBOV vaccine through three recent Ebola virus epidemics-West Africa, DRC Equateur and DRC Kivu: 4 years of excluding pregnant and lactating women and their infants from immunization"},{"title3":"CEPI to Fund Three Programmes to Develop Vaccines against the Novel Coronavirus, nCoV-2019. 23 January 2020"},{"title3":"A Dozen Vaccine Programs Underway as WHO Declares Coronavirus Public Health Emergency. Biocentury. 30 January 2020"},{"title3":"WHO Target Product Profiles for MERS-CoV Vaccines"},{"title3":"When is it acceptable to vaccinate pregnant women? Risk, ethics, and politics of governance in epidemic crises"},{"title3":"Chinese Baby Tests Positive for Coronavirus 30 Hours after Birth"},{"title3":"A Pregnant Mother Infected with the Coronavirus Gave Birth, and Her Baby Tested Positive 30 Hours Later"},{"title3":"Coronavirus: Doctors Fear Pregnant Women Can Pass on Illness after Newborn Baby Is Diagnosed"},{"title3":"Expert Reaction to Newborn Baby Testing Positive for Coronavirus in Wuhan"},{"title3":"Zika virus infection in pregnancy, microcephaly and maternal and fetal health:What we think, what we know, and what we think we know"}]},{"title2":"Novel coronavirus, poor quarantine, and the risk of pandemic","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Combined effects of prevention and quarantine on a breakout in SIR model"},{"title3":"Emerging coronaviruses genome structure, replication, and pathogenesis"},{"title3":"Coronavirus latest: WHO declares global emergency"},{"title3":"SARS epidemic unmasks age-old quarantine conundrum"}]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"Novel coronavirus: how the things are in Wuhan","References":[{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"The possible role of intrauterine infections in unexplained second trimester abortions and macerated stillbirths: a study from a single center","References":[]},{"title2":"Lactobacilli-dominated cervical microbiota in women with preterm prelabor rupture of membranes","References":[]},{"title2":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","References":[{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/. Accessed June 15, 2003."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/. Accessed June 15, 2003."},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS): laboratory diagnostic tests. Available at: http://www.who.int/csr/sars/diagnostictests/en/. Accessed October 15, 2003."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pneumonia in pregnancy"},{"title3":"Influenza occurring in pregnant women"},{"title3":"Maternal mortality in the epidemic of Asian influenza New York City 1957"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Incidence of early loss of pregnancy"},{"title3":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice"},{"title3":"Murine trophoblast failure and spontaneous abortion"},{"title3":"Teratogenic effects of ribavirin on hamster and rat embryos"},{"title3":"Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Altitude, low birth weight, and infant mortality in Colorado"},{"title3":"Infant birth weight is related to maternal arterial oxygenation at high altitude"}]}]},{"title1":"Radiological findings and clinical characteristics of pregnant women with <styled-content style="fixed-case" toggle="no">COVID</styled-content>?19 pneumonia","References":[{"title2":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","References":[{"title3":"The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li Q. Notes from the field: an outbreak of NCIP (2019-nCoV) infection in China : Wuhan, Hubei Province, 2019-2020."},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases : Wuhan, China 2019-2020."},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019."},{"title3":"Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013."},{"title3":"A novel coronavirus emerging in China : key questions for impact assessment."},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus."},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome."},{"title3":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future."},{"title3":"Coronavirus infections : more than just the common cold."},{"title3":"Another decade, another coronavirus."},{"title3":"SARS and MERS: recent insights into emerging coronaviruses."},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at January 2020."},{"title3":"How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count."}]},{"title2":"SARS and MERS: Recent insights into emerging coronaviruses","References":[{"title3":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003"},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Molecular epidemiology of the novel coronavirus that causes severe acute respiratory syndrome"},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome"},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"WHO. Summary of probably SARS cases with onset of illness from 1 November 2002 to 31 July 2003. WHO, http://www.who.int/csr/sars/country/table2004_04_21/en/ (2004)."},{"title3":"SARS-CoV infection in a restaurant from palm civet"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation"},{"title3":"Patient with new strain of coronavirus is treated in intensive care at London hospital"},{"title3":"Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res. Perspect.6, 269-278 (2015)."},{"title3":"WHO. Coronavirus infections: disease outbreak news. WHO, http://www.who.int/csr/don/26-april-2016-mers-saudi-arabia/en/ (2016)."},{"title3":"Nidovirus transcription: how to make sense...?"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Coronaviruses: an overview of their replication and pathogenesis"},{"title3":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum"},{"title3":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage"},{"title3":"Infidelity of SARS-CoV nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing"},{"title3":"Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Review of bats and SARS"},{"title3":"Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS"},{"title3":"Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation"},{"title3":"Evidence for camel-to-human transmission of MERS coronavirus"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic"},{"title3":"Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea"},{"title3":"The role of superspreading in Middle East respiratory syndrome coronavirus (MERS-CoV) transmission"},{"title3":"Middle East respiratory syndrome coronavirus superspreading event involving 81 persons, Korea 2015"},{"title3":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury"},{"title3":"Angiotensin-converting enzyme 2 protects from severe acute lung failure"},{"title3":"Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases"},{"title3":"Biomarkers in acute respiratory distress syndrome"},{"title3":"The mercurial nature of neutrophils: still an enigma in ARDS?"},{"title3":"SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues"},{"title3":"Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Genome wide identification of SARS-CoV susceptibility loci using the Collaborative Cross"},{"title3":"Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion"},{"title3":"SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism"},{"title3":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV"},{"title3":"Rapid generation of a mouse model for Middle East respiratory syndrome"},{"title3":"MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment"},{"title3":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex"},{"title3":"In vitro reconstitution of SARS-coronavirus mRNA cap methylation"},{"title3":"Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-O-methyltransferase activity"},{"title3":"Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments"},{"title3":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells"},{"title3":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism"},{"title3":"Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist"},{"title3":"Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response"},{"title3":"The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists"},{"title3":"Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets"},{"title3":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling"},{"title3":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus"},{"title3":"The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity"},{"title3":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression"},{"title3":"SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage"},{"title3":"A two-pronged strategy to suppress host protein synthesis by SARS coronavirus nsp1 protein"},{"title3":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA"},{"title3":"Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain"},{"title3":"Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin"},{"title3":"Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein"},{"title3":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists"},{"title3":"MAVS-mediated apoptosis and its inhibition by viral proteins"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Mechanisms of action of ribavirin against distinct viruses"},{"title3":"Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study"},{"title3":"Clinical analysis of the first patient with imported Middle East respiratory syndrome in China"},{"title3":"Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Development of a standard treatment protocol for severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study"},{"title3":"Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China"},{"title3":"Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts"},{"title3":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics"},{"title3":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus"},{"title3":"Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin"},{"title3":"Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays"},{"title3":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"IFN-alpha2a or IFN-beta1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study"},{"title3":"Ribavirin and interferon-alpha2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a non-human primate model of common marmoset"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen"},{"title3":"Middle East respiratory syndrome-coronavirus infection: a case report of serial computed tomographic findings in a young male patient"},{"title3":"Kim, U. J., Won, E. J., Kee, S. J., Jung, S. I. &amp; Jang, H. C. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome: a case report. Antivir. Ther.10.3851/IMP3002 (2015)."},{"title3":"Rhee, J. Y., Hong, G. &amp; Ryu, K. M. Clinical implications of five cases of Middle East respiratory syndrome coronavirus infection in South Korea Outbreak. Jpn J. Infect. Dis.10.7883/yoken.JJID.2015.445 (2016)."},{"title3":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design"},{"title3":"Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus"},{"title3":"Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals"},{"title3":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture"},{"title3":"International Severe Acute Respiratory &amp; Emerging Infection Consortium. Treatment of MERS-CoV: decision support tool. International Severe Acute Respiratory &amp; Emerging Infection Consortium, https://isaric.tghn.org/site_media/media/articles/Decision_Support_Document_v1_1_20130729.pdf (updated 29 July 2013)."},{"title3":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis"},{"title3":"A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein"},{"title3":"Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein"},{"title3":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution"},{"title3":"Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies"},{"title3":"Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection"},{"title3":"Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo"},{"title3":"A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein"},{"title3":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus"},{"title3":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection"},{"title3":"Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection"},{"title3":"3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012"},{"title3":"Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody"},{"title3":"Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay"},{"title3":"Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response"},{"title3":"Protease inhibitors targeting coronavirus and filovirus entry"},{"title3":"The role of C5a in acute lung injury induced by highly pathogenic viral infections"},{"title3":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus"},{"title3":"A decade after SARS: strategies for controlling emerging coronaviruses"},{"title3":"SARS vaccines: where are we?"},{"title3":"Middle East respiratory syndrome: current status and future prospects for vaccine development"},{"title3":"Evaluation of candidate vaccine approaches for MERS-CoV"},{"title3":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge"},{"title3":"A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates"},{"title3":"Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients"},{"title3":"Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study"},{"title3":"An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients"},{"title3":"Middle East respiratory syndrome"},{"title3":"Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description"},{"title3":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia"},{"title3":"Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome"},{"title3":"Association of higher MERS-CoV virus load with severe disease and death, Saudi Arabia, 2014"},{"title3":"Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015"},{"title3":"Animal models for SARS and MERS coronaviruses"},{"title3":"Replication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)"},{"title3":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates"},{"title3":"Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels"},{"title3":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice"},{"title3":"SARS-like WIV1-CoV poised for human emergence"}]},{"title2":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","References":[{"title3":"Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study"},{"title3":"Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB"},{"title3":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC"},{"title3":"SWISSMODEL: an automated protein homology-modeling server"},{"title3":"GISAID: Global initiative on sharing all influenza data:from vision to reality"}]},{"title2":"Coronavirus disease 2019 (COVID-19): A perspective from China","References":[]},{"title2":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application","References":[]},{"title2":"Initial cluster of novel coronavirus (2019-nCoV) infections in Wuhan, China is consistent with substantial human-to-human transmission","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Transmission dynamics and control of severe acute respiratory syndrome"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Serial interval of novel coronavirus (2019-nCoV) infections"},{"title3":"Assessing dengue control in Tokyo, 2014"},{"title3":"Report 3: Transmissibility of 2019-nCoV"},{"title3":"Real time estimation of the risk of death from novel coronavirus (2019-nCoV) infection: Inference using exported cases"},{"title3":"China Detects Large Quantity of Novel Coronavirus at Wuhan Seafood Market. 27 January 2020"},{"title3":"The Extent of transmission of novel coronavirus in Wuhan, China, 2020"},{"title3":"The rate of underascertainment of novel coronavirus (2019-nCoV) infection: Estimation using Japanese passengers data on evacuation flights"}]},{"title2":"Coronavirus disease (COVID-19) outbreak situation","References":[{"title3":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures"},{"title3":"SARS-CoV-2 is an appropriate name for the new coronavirus"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"A review of coronavirus Disease-2019 (COVID-19)"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review"},{"title3":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China"},{"title3":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status"},{"title3":"Bibliometrics basics"},{"title3":"Scientific publication, bibliometric indicators, and Hirsch's h-index"},{"title3":"Bibliometric methods: pitfalls and possibilities"},{"title3":"Global research trends of Middle East respiratory syndrome coronavirus: a bibliometric analysis"},{"title3":"Global research trends in West Nile virus from 1943 to 2016: a bibliometric analysis"},{"title3":"Analysing published global Ebola virus disease research using social network analysis"},{"title3":"Bibliometric analysis of literature in AIDS-related stigma and discrimination"},{"title3":"Bibliometric analysis of oncolytic virus research, 2000 to 2018"},{"title3":"Bibliometric analysis of Oropouche research: impact on the surveillance of emerging arboviruses in Latin America"},{"title3":"Bibliometric assessment of scientific production of literature of West Nile virus"},{"title3":"Bibliometric indicators of the Zika outbreak"},{"title3":"Bibliometric study of international scientific production in O'nyong-nyong virus during the years 1962-2016"},{"title3":"Bibliometrics of global Ebola virus disease research as seen through science citation index expanded during 1987-2015"},{"title3":"Global research output on HIV/AIDS-related medication adherence from 1980 to 2017"},{"title3":"Del Carpio OL. Guillain-Barre syndrome associated with zika virus infection in the Americas: a bibliometric study. Neurologia. 2020;35(6):426-9."},{"title3":"Scientometric analysis of research on Zika virus"},{"title3":"When has it been studied about La Crosse virus?: Bibliometric analysis of world scientific production"},{"title3":"Andersen JP, Nielsen MW, Simone NL, Lewiss RE, Jagsi R. COVID-19 medical papers have fewer women first authors than expected. Elife. 2020;9:e58807."},{"title3":"A Bibliometric analysis of COVID-19 research activity: a call for increased output"},{"title3":"The scientific literature on coronaviruses, COVID-19 and its associated safety-related research dimensions: a scientometric analysis and scoping review"},{"title3":"Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: a bibliometric analytic report"},{"title3":"Coronavirus disease 2019: a bibliometric analysis and review"},{"title3":"The status and trends of coronavirus research: a global bibliometric and visualized analysis"},{"title3":"COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis"},{"title3":"Zhai F, Zhai Y, Cong C, Song T, Xiang R, Feng T, Liang Z, Zeng Y, Yang J, Yang J, et al. Research Progress of Coronavirus Based on Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(11):3766."},{"title3":"Zhou Y, Chen L. Twenty-Year Span of Global Coronavirus Research Trends: A Bibliometric Analysis. Int J Environ Res Public Health. 2020;17(9):3082."},{"title3":"Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses"},{"title3":"Comparisons of citations in web of science, Scopus, and Google scholar for articles published in general medical journals"},{"title3":"The journal coverage of web of science and Scopus: a comparative analysis"},{"title3":"Global research trends in microbiome-gut-brain axis during 2009-2018: a bibliometric and visualized study"},{"title3":"Global scientific trends on aflatoxin research during 1998-2017: a bibliometric and visualized study"},{"title3":"Arab world's growing contribution to global leishmaniasis research (1998-2017): a bibliometric study"},{"title3":"Polimeni a: coronavirus disease (COVID-19): a machine learning Bibliometric analysis"},{"title3":"Software survey: VOSviewer, a computer program for bibliometric mapping"},{"title3":"Citation-based clustering of publications using CitNetExplorer and VOSviewer"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-42."},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study"},{"title3":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro"},{"title3":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome"},{"title3":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1"},{"title3":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor"},{"title3":"Transmission of 2019-nCoV infection from an asymptomatic contact in Germany"},{"title3":"HLH across Speciality collaboration UK: COVID-19: consider cytokine storm syndromes and immunosuppression"},{"title3":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients"},{"title3":"Ten-years trend of dengue research in Indonesia and south-east Asian countries: a bibliometric analysis"},{"title3":"Bibliometric analysis of global Lassa fever research (1970-2017): a 47 - year study"},{"title3":"Global research trends of World Health Organization's top eight emerging pathogens"},{"title3":"Dengue research: a bibliometric analysis of worldwide and Arab publications during 1872-2015"},{"title3":"Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C et al: First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020. Euro Surveill. 2020;25(6):2000094."},{"title3":"Marchand-Senecal X, Kozak R, Mubareka S, Salt N, Gubbay JB, Eshaghi A, Allen V, Li Y, Bastien N, Gilmour M, et al. Diagnosis and Management of First Case of COVID-19 in Canada: lessons applied from SARS. Clin Infect Dis. 2020. 10.1093/cid/ciaa227."},{"title3":"Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak"},{"title3":"Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):1335."},{"title3":"Spiteri G, Fielding J, Diercke M, Campese C, Enouf V, Gaymard A, Bella A, Sognamiglio P, Sierra Moros MJ, Riutort AN, et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European region, 24 January to 21 February 2020. Euro Surveill. 2020;25(9):2000178."},{"title3":"A Bibliometric analysis of publications on spinal cord injury during 1980-2018"},{"title3":"Three options for citation tracking: Google scholar, Scopus and Web of Science"},{"title3":"A bibliometric analysis of the global research on biosimilars"},{"title3":"Global scientific production on illicit drug addiction: a two-decade analysis"},{"title3":"Taking the next step in publication productivity analysis in pediatric neurosurgery"},{"title3":"Global output of research on epidermal parasitic skin diseases from 1967 to 2017"},{"title3":"Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis"},{"title3":"Bibliometric analysis of research on the role of intestinal microbiota in obesity"},{"title3":"Investigating global trends in paraquat intoxication research from 1962 to 2015 using bibliometric analysis"},{"title3":"Bibliometrics: tracking research impact by selecting the appropriate metrics"}]},{"title2":"H1N1 2009 influenza virus infection during pregnancy in the USA","References":[]},{"title2":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","References":[{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/. Accessed June 15, 2003."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/. Accessed June 15, 2003."},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS): laboratory diagnostic tests. Available at: http://www.who.int/csr/sars/diagnostictests/en/. Accessed October 15, 2003."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pneumonia in pregnancy"},{"title3":"Influenza occurring in pregnant women"},{"title3":"Maternal mortality in the epidemic of Asian influenza New York City 1957"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Incidence of early loss of pregnancy"},{"title3":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice"},{"title3":"Murine trophoblast failure and spontaneous abortion"},{"title3":"Teratogenic effects of ribavirin on hamster and rat embryos"},{"title3":"Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Altitude, low birth weight, and infant mortality in Colorado"},{"title3":"Infant birth weight is related to maternal arterial oxygenation at high altitude"}]},{"title2":"Potential maternal and infant outcomes from coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections","References":[]},{"title2":"Middle east respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of the literature","References":[{"title3":"Emergency cesarean section in an epidemic of the Middle East respiratory syndrome: a case report"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"MERS-CoV infection in a pregnant woman in Korea"}]},{"title2":"Office of state administration of traditional Chinese medicine. Notice on the issuance of a programme for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial fifth edition)","References":[]},{"title2":"A novel coronavirus from patients with pneumonia in China, 2019","References":[{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition"},{"title3":"Importation and human-to-human transmission of a novel coronavirus in Vietnam"},{"title3":"2019 novel coronavirus (2019-nCoV) outbreak: a new challenge"},{"title3":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"},{"title3":"Novel Wuhan (2019-nCoV) coronavirus"},{"title3":"Severe acute respiratory syndrome coronavirus phylogeny: toward consensus"},{"title3":"Diagnosis and treatment of new coronavirus pneumonia (trial version 7) [J / OL]. Tianjin J Tradit Chin Med. 2020;1-5. http://kns.cnki.net/kcms/detail/12.1349.R.20200304.1638.006.html. Accessed 3 June 2020."},{"title3":"Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19"},{"title3":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus"},{"title3":"Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection"},{"title3":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa"},{"title3":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis"},{"title3":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation"},{"title3":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways"},{"title3":"Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome"},{"title3":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV"},{"title3":"Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients"},{"title3":"Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study"},{"title3":"C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early"},{"title3":"Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study"},{"title3":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China"},{"title3":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)"},{"title3":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study"},{"title3":"Human ipsc-derived cardiomyocytes are susceptible to Sars-Cov-2 infection"},{"title3":"Cardiovascular complications in COVID-19"},{"title3":"COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?"},{"title3":"Endothelial cell infection and endotheliitis in COVID-19"}]},{"title2":"Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia","References":[]},{"title2":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","References":[]},{"title2":"A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)","References":[{"title3":"Distinguishing opinion from evidence in guidelines"},{"title3":"GRADE handbook, GRADE working group. 2013. https://gdt.gradepro.org/app/handbook/handbook.html. Accessed 22 Jan 2020."},{"title3":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"},{"title3":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome"},{"title3":"Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (Full version). Yixue Xinzhi. 2020;30(1):35-64. 10.12173/j.issn.1004-5511.2020.01.09 [Article in China]."},{"title3":"Chan JFW, Yuan S, Kok KH, To KKT, Chu HC, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020. 10.1016/S0140-6736(20)30154-9."},{"title3":"Health Emergency Office of National Health Commission of the PRC. Update on the epidemic of novel coronavirus (2019-nCoV) infected pneumonia as at 24:00 on 26 January. http://www.nhc.gov.cn/xcs/yqfkdt/202001/3882fdcdbfdc4b4fa4e3a829b62d518e.shtml. Accessed 26 Jan 2020."},{"title3":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020. https://doi.org/10.1038/s41586-020-2012-7."},{"title3":"Perlman S. Another decade, another coronavirus. N Engl J Med. 2020. 10.1056/NEJMe2001126."},{"title3":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020. 10.1056/NEJMoa2001017."},{"title3":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. 10.1016/S0140-6736(20)30183-5."},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Middle East respiratory syndrome infection control and prevention guideline for healthcare facilities"},{"title3":"Image of pulmonary and diagnosis of atypicalnovel coronavirus (2019-nCoV) infected pneumonia: case series of 14 patients"},{"title3":"Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study"},{"title3":"Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings"},{"title3":"Treatment of severe acute respiratory syndrome"},{"title3":"MERS-COV disease associated ARDS -a case report"},{"title3":"The possibility of using Lopinave/Litonawe (LPV/r) as treatment for novel coronavirus 2019-nCov pneumonia: a quick systematic review based on earlier coronavirus clinical studies"},{"title3":"Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques"},{"title3":"Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset"},{"title3":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study"},{"title3":"Middle east respiratory syndrome (MERS): a systematic review"},{"title3":"Clinical analysis of 190 cases of outbreak with atypical pneumonia in Guangzhou in spring, 2003"},{"title3":"Use of glucocorticoid in treatment of severe acute respiratory syndrome cases"},{"title3":"Glucocorticoid-induced diabetes in severe acute respiratory syndrome: the impact of high dosage and duration of methylprednisolone therapy"},{"title3":"Acute respiratory distress syndrome: the Berlin Definition"}]},{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV","References":[{"title3":"Coronaviruses: genome structure, replication, and pathogenesis"},{"title3":"Bats are natural reservoirs of SARS-like coronaviruses"},{"title3":"Emerging diseases. researchers scramble to understand camel connection to MERS"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Lung pathology of fatal severe acute respiratory syndrome"},{"title3":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China"},{"title3":"Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in-situ hybridization study of fatal cases"},{"title3":"Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome"},{"title3":"Elucidating the molecular physiopathology of acute respiratory distress syndrome in severe acute respiratory syndrome patients"},{"title3":"An interferon-gamma-related cytokine storm in SARS patients"},{"title3":"Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome"},{"title3":"Analysis of serum cytokines in patients with severe acute respiratory syndrome"},{"title3":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome"},{"title3":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses"},{"title3":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice"},{"title3":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014"},{"title3":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection:clinicopathological and ultrastructural study"},{"title3":"Value of autopsy emphasized in the case report of a single patient with Middle East respiratory syndrome"},{"title3":"Dipeptidyl peptidase 4 distribution in the human respiratory tract: implications for the Middle East respiratory syndrome"},{"title3":"A case report of a middle east respiratory syndrome survivor with kidney biopsy results"},{"title3":"Differential expression of the Middle East respiratory syndrome coronavirus receptor in the upper respiratory tracts of humans and dromedary camels"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response"},{"title3":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis"},{"title3":"Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways"},{"title3":"MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2"},{"title3":"A novel coronavirus outbreak of global health concern"},{"title3":"Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"}]},{"title2":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","References":[]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records","References":[]},{"title2":"Chest CT for typical 2019-nCoV pneumonia: Relationship to negative RT-PCR testing","References":[]},{"title2":"Low and ultra-low dose radiation in CT: Opportunities and limitations","References":[]}]},{"title1":"Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China","References":[{"title2":". Coronavirus (COVID-19). 2020 ().","References":[{"title3":"Coronavirus (COVID-19) Dashboard"},{"title3":"Build back fairer: the COVID-19 Marmot review"},{"title3":"COVID-19: review of disparities in risks and outcomes"},{"title3":"Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study"},{"title3":"UK immunisation schedule: the green book, chapter 11"},{"title3":"Predictors of intention to vaccinate against COVID-19: results of a nationwide survey"},{"title3":"Tracking the global spread of vaccine sentiments: the global response to Japan's suspension of its HPV vaccine recommendation"},{"title3":"Measles outbreaks in a population with declining vaccine uptake"},{"title3":"Impact of COVID-19 vaccines on mortality in England: December 2020 to February 2021"},{"title3":"Coronavirus and vaccine hesitancy, great Britain: 17 February to 14 March 2021"},{"title3":"Coronavirus and vaccine hesitancy, great Britain: 26 may to 20 June 2021"},{"title3":"Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: results from the UK-REACH prospective nationwide cohort study"},{"title3":"A rapid systematic review of factors influencing COVID-19 vaccination uptake in minority ethnic groups in the UK"},{"title3":"The public views of and reactions to the COVID-19 pandemic in England- a qualitative study with diverse ethnicities"},{"title3":"A guide to using the theoretical domains framework of behaviour change to investigate implementation problems"},{"title3":"Population of England and Wales"},{"title3":"Ethnic minorities Maryland scholastic"},{"title3":"Summary of product characteristics for COVID-19 vaccine Pfizer/BioNTech"},{"title3":"NVivo qualitative data analysis software"},{"title3":"Monitoring sociodemographic inequality in COVID-19 vaccination uptake in England: a national linked data study"},{"title3":"Tackling barriers to COVID-19 vaccine uptake in London: a mixed-methods evaluation"},{"title3":"Trust and experiences of national health service healthcare do not fully explain demographic disparities in coronavirus vaccination uptake in the UK: a cross-sectional study"},{"title3":"Characteristics associated with COVID-19 vaccine uptake among adults aged 50 years and above in England (8 December 2020-17 may 2021): a population-level observational study"},{"title3":"Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY. b2021"},{"title3":"A study of ethnic, gender and educational differences in attitudes toward COVID-19 vaccines in Israel - implications for vaccination implementation policies"},{"title3":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (siren): a prospective, multicentre, cohort study"},{"title3":"National study of youth opinions on vaccination for COVID-19 in the U.S"},{"title3":"Trust in health information sources and its associations with COVID-19 disruptions to social relationships and health services among people living with HIV"},{"title3":"Anticipating hopes, fears and expectations towards COVID-19 vaccines: a qualitative interview study in seven European countries"},{"title3":"Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England"},{"title3":"Race, ethnicity and COVID-19 vaccination: a qualitative study of UK healthcare staff"},{"title3":"Attitudes towards vaccines and intention to vaccinate against COVID-19: implications for public health communications"},{"title3":"Maternal vaccines during the Covid-19 pandemic:A qualitative interview study with UK pregnant women"},{"title3":"Strategies and action points to ensure equitable uptake of COVID-19 vaccinations: a national qualitative interview study to explore the views of undocumented migrants, asylum seekers, and refugees"},{"title3":"Attitudes, current behaviours and barriers to public health measures that reduce COVID-19 transmission: a qualitative study to inform public health messaging"},{"title3":"More vaccines for children? parents' views"},{"title3":"Parents with doubts about vaccines: which vaccines and reasons why"},{"title3":"Determinants of vaccination uptake in risk populations: a comprehensive literature review"},{"title3":"Efficacy or delivery? an online discrete choice experiment to explore preferences for COVID-19 vaccines in the UK"},{"title3":"United States COVID-19 vaccination preferences (CVP): 2020 hindsight"},{"title3":"Confidence, acceptance and willingness to pay for the COVID-19 vaccine among migrants in Shanghai, China: a cross-sectional study"},{"title3":"Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology"},{"title3":"Associations between COVID-19 misinformation exposure and belief with COVID-19 knowledge and preventive behaviors: cross-sectional online study"},{"title3":"Author correction: measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA"},{"title3":"Information and disinformation: social media in the COVID-19 crisis"},{"title3":"&quot;Social Media Misinformation&quot;-An Epidemic within the COVID-19 Pandemic"},{"title3":"COVID-19 related misinformation on social media: a qualitative study from Iran"},{"title3":"COVID-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence"},{"title3":"Using behavioural science to develop public health messages for racial and ethnic minority communities during COVID-19 [Preprint]"},{"title3":"Acceptability of a hypothetical Zika vaccine among women from Colombia and Spain exposed to ZIKV: a qualitative study"},{"title3":"Covid-19: global attitudes towards a COVID-19 vaccine"},{"title3":"Exclusive: Fewer black and Filipino NHS staff vaccinated amid 'hesitancy' concern"},{"title3":"Strategies for addressing vaccine hesitancy - A systematic review"},{"title3":"COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey"},{"title3":"Community champions to give COVID-19 vaccine advice and boost take up"},{"title3":"Scientific pandemic insights group on behaviour subgroup of UK scientific Advisory group for emergencies. The role of community champion networks to increase engagement in the context of COVID19: evidence and best practice"},{"title3":"(SAGE), S.A.G.f.E. factors influencing COVID-19 vaccine uptake among minority ethnic groups, 17 December 2020"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records.","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study.","References":[{"title3":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle"},{"title3":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - the latest 2019 novel coronavirus outbreak in Wuhan, China"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance"},{"title3":"Novel coronavirus:China"},{"title3":"Novel coronavirus:Thailand (ex-China)"},{"title3":"Novel coronavirus:Japan (ex-China)"},{"title3":"Novel coronavirus:Republic of Korea (ex-China)"},{"title3":"Coronavirus disease 2019 (COVID-19) situation report 53"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission"},{"title3":"Wuhan coronavirus has strong ability to infect humans"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Effects of intrauterine exposure to synthetic glucocorticoids on fetal, newborn, and infant hypothalamic-pituitary-adrenal axis function in humans: a systematic review"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding"},{"title3":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Clinical characteristics of coronavirus disease 2019 in China"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"}]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China.","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Seasonal and 2009 pandemic influenza A (H1N1) virus infection during pregnancy: a population-based study of hospitalized cases.","References":[]}]},{"title1":"Coronavirus disease 2019 in pregnant women: a report based on 116 cases","References":[{"title2":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","References":[{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: adescriptivestudy"},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study"},{"title3":"First case of 2019 novel coronavirus in the United States"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Lung CT image of a confirmed case of the 2019 novel coronavirus (2019-nCoV) infected pneumonia (With differential diagnosis of the SARS)"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Role of neutrophil to lymphocyte and monocyte to lymphocyte ratios in the diagnosis of bacterial infection in patients with fever"},{"title3":"Coronavirus infections-more than just the common cold"},{"title3":"The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study"},{"title3":"A new coronavirus associated with human respiratory disease in China"},{"title3":"Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: a prospective cohort study"},{"title3":"Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill"},{"title3":"Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study"}]},{"title2":"Novel coronavirus - China. 2020","References":[]},{"title2":"COVID-19 dashboard. 2020","References":[]},{"title2":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","References":[{"title3":"Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus"},{"title3":"The molecular biology of coronaviruses"},{"title3":"Attachment of mouse hepatitis virus to O-acetylated sialic acid is mediated by hemagglutinin-esterase and not by the spike protein"},{"title3":"Rotavirus and coronavirus associated diarrhoea in domestic animals"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Detection of a group 2 coronavirus in dogs with canine infectious respiratory disease"},{"title3":"Pathogenesis of demyelination induced by a mouse hepatitis"},{"title3":"Transmissible gastroenteritis of swine: virus-intestinal cell interactions. II. Electron microscopy of the epithelium in isolated jejunal loops"},{"title3":"Transmissible gastroenteritis of swine: virus-intestinal cell interactions. I. Immunofluorescence, histopathology and virus production in the small intestine through the course of infection"},{"title3":"Replication of an enteric bovine coronavirus in intestinal organ cultures"},{"title3":"Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683"},{"title3":"Recovery and Characterization of a Coronavirus from Military Dogs with Diarrhea"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Recently discovered human coronaviruses"},{"title3":"Cultivation of a novel type of common-cold virus in organ cultures"},{"title3":"Genomic analysis of 15 human coronaviruses OC43 (HCoV-OC43s) circulating in France from 2001 to 2013 reveals a high intra-specific diversity with new recombinant genotypes"},{"title3":"Medical reviews. Coronaviruses"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"MERS: emergence of a novel human coronavirus"},{"title3":"Coronavirus infections in working adults. Eight-year study with 229 E and OC 43"},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong"},{"title3":"A new virus isolated from the human respiratory tract"},{"title3":"Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease"},{"title3":"Signs and symptoms in common colds"},{"title3":"Human coronavirus NL63, a new respiratory virus"},{"title3":"A previously undescribed coronavirus associated with respiratory disease in humans"},{"title3":"Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children"},{"title3":"Understanding human coronavirus HCoV-NL63"},{"title3":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia"},{"title3":"More and more coronaviruses: human coronavirus HKU1"},{"title3":"Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia"},{"title3":"Coronavirus HKU1 and other coronavirus infections in Hong Kong"},{"title3":"Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method"},{"title3":"Coronavirus HKU1 infection in the United States"},{"title3":"Evidence of human coronavirus HKU1 and human bocavirus in Australian children"},{"title3":"Detection of the new human coronavirus HKU1: a report of 6 cases"},{"title3":"Coronavirus HKU1 in children, Brazil, 1995"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"Middle East respiratory syndrome"},{"title3":"Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients"},{"title3":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study"},{"title3":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection"},{"title3":"Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection"},{"title3":"MERS in South Korea and China: a potential outbreak threat?"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Identification of a novel coronavirus in bats"},{"title3":"Coronaviruses post-SARS: update on replication and pathogenesis"},{"title3":"Antibodies to SARS coronavirus in civets"},{"title3":"Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms"},{"title3":"Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events"},{"title3":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor"},{"title3":"ORF8-related genetic evidence for Chinese horseshoe bats as the source of human severe acute respiratory syndrome coronavirus"},{"title3":"Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study"},{"title3":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease"},{"title3":"MERS coronavirus in dromedary camel herd, Saudi Arabia"},{"title3":"Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014"},{"title3":"MERS coronaviruses in dromedary camels, Egypt"},{"title3":"Concerns about misinterpretation of recent scientific data implicating dromedary camels in epidemiology of Middle East respiratory syndrome (MERS)"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia"},{"title3":"Mosaic structure of human coronavirus NL63, one thousand years of evolution"},{"title3":"Does IBV change slowly despite the capacity of the spike protein to vary greatly?"},{"title3":"Genetic drift of human coronavirus OC43 spike gene during adaptive evolution"},{"title3":"Moderate mutation rate in the SARS coronavirus genome and its implications"},{"title3":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus"},{"title3":"Coronavirus diversity, phylogeny and interspecies jumping"},{"title3":"Infectious diseases emerging from Chinese wet-markets: zoonotic origins of severe respiratory viral infections"},{"title3":"Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1"},{"title3":"Recombination between nonsegmented RNA genomes of murine coronaviruses"},{"title3":"Evidence of recombinant strains of porcine epidemic diarrhea virus, United States, 2013"},{"title3":"Emergence of pathogenic coronaviruses in cats by homologous recombination between feline and canine coronaviruses"},{"title3":"Recombinant canine coronaviruses related to transmissible gastroenteritis virus of Swine are circulating in dogs"},{"title3":"Molecular epidemiology of human coronavirus OC43 reveals evolution of different genotypes over time and recent emergence of a novel genotype due to natural recombination"},{"title3":"Genotype shift in human coronavirus OC43 and emergence of a novel genotype by natural recombination"},{"title3":"Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia"},{"title3":"Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV"},{"title3":"Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus"},{"title3":"Origin and possible genetic recombination of the Middle East respiratory syndrome coronavirus from the first imported case in China: phylogenetics and coalescence analysis"},{"title3":"Coronavirus 229E-related pneumonia in immunocompromised patients"},{"title3":"Coronaviruses in children, Greece"},{"title3":"Epidemiological and clinical features of human coronavirus infections among different subsets of patients"},{"title3":"Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism"},{"title3":"Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Multiple organ infection and the pathogenesis of SARS"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study"},{"title3":"A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium"},{"title3":"Human coronavirus NL63 infection in Canada"},{"title3":"Croup is associated with the novel coronavirus NL63"},{"title3":"Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China"},{"title3":"The common cold: a review of the literature"},{"title3":"Detection of viruses identified recently in children with acute wheezing"},{"title3":"State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans"},{"title3":"Viral Shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection"}]},{"title2":"A novel coronavirus associated with severe acute respiratory syndrome","References":[{"title3":"Ahmadi KS, Vahabizad F, Banihashemi G, Sahraian MA,  Gheini MR, Eslami M, Marhamati H, Mirhadi MS (2020) Ischemic stroke in patients with COVID-19 disease: a report of 10 cases from Iran Cerebrovasc Dis 1-6 10.1159/000513279"},{"title3":"Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19"},{"title3":"COVID-19 infection recurrence presenting with meningoencephalitis"},{"title3":"Matos AR, Quintas-Neves M, Oliveira AI, Dias L, Marques S, Carvalho R, Alves JN (2020) COVID-19 associated central nervous system vasculopathy Can J Neurol Sci 1-6 10.1017/cjn.2020.1092020.1092020.1092020.109"},{"title3":"Focal cerebral arteriopathy in a COVID-19 pediatric patient"},{"title3":"An updated review of the association of host genetic factors with susceptibility and resistance to COVID-19"},{"title3":"A first case of meningitis/encephalitis associated with SARS-Coronavirus-2"},{"title3":"COVID-19, SARS and MERS: a neurological perspective"},{"title3":"Frontier therapeutics and vaccine strategies for sars-cov-2 (COVID-19): a review"},{"title3":"A review of Coronavirus Disease-2019 (COVID-19)"},{"title3":"Neurological manifestations in severe acute respiratory syndrome"},{"title3":"Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C (2020) Nervous system involvement after infection with COVID-19 and other coronaviruses Brain Behav Immun 18-22 10.1016/j.bbi.2020.03.0312020.03.0312020.03.0312020.03.031"},{"title3":"Encephalitis as a clinical manifestation of COVID-19"},{"title3":"Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review"}]},{"title2":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","References":[]},{"title2":"Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003","References":[]},{"title2":"Middle East respiratory syndrome coronavirus (MERS-CoV). MERS monthly summary, November 2019","References":[]},{"title2":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","References":[{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/. Accessed June 15, 2003."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome"},{"title3":"Coronavirus as a possible cause of severe acute respiratory syndrome"},{"title3":"A cluster of cases of severe acute respiratory syndrome in Hong Kong"},{"title3":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en/. Accessed June 15, 2003."},{"title3":"Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality"},{"title3":"World Health Organization. Severe acute respiratory syndrome (SARS): laboratory diagnostic tests. Available at: http://www.who.int/csr/sars/diagnostictests/en/. Accessed October 15, 2003."},{"title3":"A major outbreak of severe acute respiratory syndrome in Hong Kong"},{"title3":"Pneumonia in pregnancy"},{"title3":"Influenza occurring in pregnant women"},{"title3":"Maternal mortality in the epidemic of Asian influenza New York City 1957"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Incidence of early loss of pregnancy"},{"title3":"Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice"},{"title3":"Murine trophoblast failure and spontaneous abortion"},{"title3":"Teratogenic effects of ribavirin on hamster and rat embryos"},{"title3":"Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Altitude, low birth weight, and infant mortality in Colorado"},{"title3":"Infant birth weight is related to maternal arterial oxygenation at high altitude"}]},{"title2":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","References":[{"title3":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses"},{"title3":"Coronavirus avian infectious bronchitis virus"},{"title3":"Pathogenicity of turkey coronavirus in turkeys and chickens"},{"title3":"Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin"},{"title3":"Severe acute respiratory syndrome"},{"title3":"SARS: epidemiology"},{"title3":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia"},{"title3":"A dynamic compartmental model for the Middle East respiratory syndrome outbreak in the Republic of Korea: a retrospective analysis on control interventions and superspreading events"},{"title3":"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015"},{"title3":"A novel coronavirus genome identified in a cluster of pneumonia cases:Wuhan, China 2019-2020"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Two-tube multiplex real-time reverse transcription PCR to detect six human coronaviruses"},{"title3":"Fast and accurate short read alignment with Burrows-Wheeler transform"},{"title3":"RAPSearch2: a fast and memory-efficient protein similarity search tool for next-generation sequencing data"},{"title3":"Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings"},{"title3":"CDD/SPARCLE: functional classification of proteins via subfamily domain architectures"},{"title3":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination"},{"title3":"Parallelization of MAFFT for large-scale multiple sequence alignments"},{"title3":"RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies"},{"title3":"Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats"},{"title3":"Structure, function, and evolution of coronavirus spike proteins"},{"title3":"Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond"},{"title3":"MERS-CoV spike protein: targets for vaccines and therapeutics"},{"title3":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine"},{"title3":"Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits"},{"title3":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor"},{"title3":"Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26"},{"title3":"Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4"},{"title3":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26"},{"title3":"SWISS-MODEL: homology modelling of protein structures and complexes"},{"title3":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody"},{"title3":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China"},{"title3":"Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia"},{"title3":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin"}]},{"title2":"WHO Director-General's opening remarks at the media briefing on COVID-1 - 3 March 2020","References":[]},{"title2":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China","References":[]},{"title2":"The Spanish flu in Iceland 1918. Lessons in medicine and history","References":[]},{"title2":"H1N1 2009 influenza virus infection during pregnancy in the USA","References":[]},{"title2":"Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","References":[{"title3":"Epidemic and emerging coronaviruses (severe acute respiratory syndrome and Middle East respiratory syndrome)"},{"title3":"From SARS to MERS, thrusting coronaviruses into the spotlight"},{"title3":"Origin and evolution of pathogenic coronaviruses"},{"title3":"Coronaviridae"},{"title3":"Another decade, another coronavirus"},{"title3":"Severe acute respiratory syndrome: Historical, epidemiologic, and clinical features"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Wuhan Seafood Market May Not Be Source of Novel Virus Spreading Globally"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-nCoV)"},{"title3":"Novel Coronavirus (2019-nCoV). Situation Report-20"},{"title3":"W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Risk factors associated with the increasing prevalence of pneumonia during pregnancy"},{"title3":"Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome?"},{"title3":"Indirect obstetric deaths in the state of Michigan 1960-1968"},{"title3":"Pneumonia during pregnancy"},{"title3":"Emerging infections and pregnancy"},{"title3":"Immunobiologic adaptations of pregnancy"},{"title3":"Acute respiratory failure in pregnancy due to staphylococcal pneumonia"},{"title3":"Pregnancy and the lung"},{"title3":"Influenza occurring in pregnant women; a statistical study of thirteen hundred and fifty cases"},{"title3":"Observations on excess mortality associated with epidemic influenza"},{"title3":"Learning from SARS: Renewal of Public Health in Canada:SARS in Canada: Anatomy of an Outbreak"},{"title3":"Reporting Incidence of Severe Acute Respiratory Syndrome (SARS) Appendix A: Chronology"},{"title3":"Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS)"},{"title3":"Severe acute respiratory syndrome and pregnancy"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Infection control for SARS in a tertiary neonatal centre"},{"title3":"SARS in newborns and children"},{"title3":"No. 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome"},{"title3":"Clinical analysis of pregnancy in second and third trimesters complicated severe acute respiratory syndrome"},{"title3":"SARS and pregnancy: A case report"},{"title3":"SARS in pregnancy"},{"title3":"SARS during pregnancy, United States"},{"title3":"Severe acute respiratory syndrome in pregnancy"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Severe acute respiratory syndrome (SARS) in neonates and children"},{"title3":"The placentas of patients with severe acute respiratory syndrome: A pathophysiological evaluation"},{"title3":"Identification of severe acute respiratory syndrome in Canada"},{"title3":"Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome"},{"title3":"The SARS epidemic in Hong Kong: What lessons have we learned?"},{"title3":"Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)"},{"title3":"Middle East Respiratory Syndrome (MERS) Background"},{"title3":"Middle East respiratory syndrome coronavirus infection during pregnancy: A report of 5 cases from Saudi Arabia"},{"title3":"Middle East Respiratory Syndrome (MERS) Fact Sheet"},{"title3":"MERS-CoV infection in pregnant woman in Korea"},{"title3":"Middle East Respiratory Syndrome (MERS) Overview"},{"title3":"Family cluster of Middle East respiratory syndrome coronavirus infections"},{"title3":"Novel coronavirus infections in Jordan, April 2012: Epidemiological findings from a retrospective investigation"},{"title3":"2014 MERS-CoV outbreak in Jeddah:A link to health care facilities"},{"title3":"Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi"},{"title3":"Middle East respiratory syndrome: What we learned from the 2015 outbreak in the Republic of Korea"},{"title3":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoir"},{"title3":"Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Impact of Middle East respiratory syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome"},{"title3":"An Overview of the latest infectious diseases around the world"},{"title3":"Middle East respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates 2013"},{"title3":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of literature"},{"title3":"Stillbirth during infection with Middle East respiratory syndrome coronavirus"},{"title3":"Update on therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)"},{"title3":"Vertical transmission of human coronavirus. Prospective pilot study"},{"title3":"Materno-fetal transmission of human coronaviruses: A prospective pilot study"},{"title3":"Emerging respiratory viruses: Challenges and vaccine strategies"},{"title3":"Duration of antibody responses after severe acute respiratory syndrome"},{"title3":"Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus"},{"title3":"Clinical trials and administration of Zika virus vaccine in pregnant women: Lessons (that should have been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation"},{"title3":"Being pregnant during the Kivu Ebola virus outbreak in DR Congo: The rVSV-ZEBOV vaccine and its accessibility by mothers and infants during humanitarian crises and in conflict areas"},{"title3":"Maternal and infant death and the rVSV-ZEBOV vaccine through three recent Ebola virus epidemics-West Africa, DRC Equateur and DRC Kivu: 4 years of excluding pregnant and lactating women and their infants from immunization"},{"title3":"CEPI to Fund Three Programmes to Develop Vaccines against the Novel Coronavirus, nCoV-2019. 23 January 2020"},{"title3":"A Dozen Vaccine Programs Underway as WHO Declares Coronavirus Public Health Emergency. Biocentury. 30 January 2020"},{"title3":"WHO Target Product Profiles for MERS-CoV Vaccines"},{"title3":"When is it acceptable to vaccinate pregnant women? Risk, ethics, and politics of governance in epidemic crises"},{"title3":"Chinese Baby Tests Positive for Coronavirus 30 Hours after Birth"},{"title3":"A Pregnant Mother Infected with the Coronavirus Gave Birth, and Her Baby Tested Positive 30 Hours Later"},{"title3":"Coronavirus: Doctors Fear Pregnant Women Can Pass on Illness after Newborn Baby Is Diagnosed"},{"title3":"Expert Reaction to Newborn Baby Testing Positive for Coronavirus in Wuhan"},{"title3":"Zika virus infection in pregnancy, microcephaly and maternal and fetal health:What we think, what we know, and what we think we know"}]},{"title2":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","References":[{"title3":"A novel coronavirus from patients with pneumonia in China, 2019"},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China"},{"title3":"Notice on prevention and control of pneumonia in children and pregnant women with new coronavirus infection"},{"title3":"New coronavirus pneumonia prevention and control program (4th edn)"},{"title3":"Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Interim guidance"},{"title3":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance"},{"title3":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR"},{"title3":"The Spanish flu in Iceland 1918. Lessons in medicine and history"},{"title3":"H1N1 2009 influenza virus infection during pregnancy in the USA"},{"title3":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome"},{"title3":"Coronavirus envelope protein: current knowledge"},{"title3":"Novel 2019 coronavirus genome"},{"title3":"SARS and MERS: recent insights into emerging coronaviruses"},{"title3":"A pneumonia outbreak associated with a new coronavirus of probable bat origin"},{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia"},{"title3":"Infants born to mothers with severe acute respiratory syndrome"},{"title3":"Rubella and pregnancy: diagnosis, management and outcomes"},{"title3":"Wuhan Tongji Hospital diagnoses first case of neonatal infection with new coronavirus"},{"title3":"Neonatal coronavirus expert confirmed at 30 hours of birth: vertical transmission from mother to infant"}]},{"title2":"Clinical analysis of 10 neonates born to mothers with 2019-nCov pneumonia","References":[]},{"title2":"Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy","References":[]},{"title2":"Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province","References":[]},{"title2":"Clinical characteristics of COVID-19 in pregnancy: analysis of nine cases","References":[]},{"title2":"4th ed (in Chinese)","References":[]},{"title2":"5th ed (in Chinese)","References":[]},{"title2":"6th ed (in Chinese)","References":[]},{"title2":"Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7)","References":[]},{"title2":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","References":[{"title3":"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"},{"title3":"GRADE guidelines: 2. Framing the question and deciding on important outcomes"},{"title3":"Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination"},{"title3":"Usefulness of sputum Gram staining in community-acquired pneumonia [in Japanese]"},{"title3":"Does sputum culture affect the management and/or outcome of community-acquired pneumonia?"},{"title3":"Sputum examination in the clinical management of community-acquired pneumonia [in Portuguese]"},{"title3":"Impact of guideline-concordant microbiological testing on outcomes of pneumonia"},{"title3":"Limited value of routine microbiological diagnostics in patients hospitalized for community-acquired pneumonia"},{"title3":"Initial microbiologic studies did not affect outcome in adults hospitalized with community-acquired pneumonia"},{"title3":"Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study"},{"title3":"Factors associated with unknown aetiology in patients with community-acquired pneumonia"},{"title3":"Applying sputum as a diagnostic tool in pneumonia: limited yield, minimal impact on treatment decisions"},{"title3":"Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system"},{"title3":"Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations"},{"title3":"Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization"},{"title3":"Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization"},{"title3":"Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia"},{"title3":"Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia"},{"title3":"Use of tracheal aspirate culture in newly intubated patients with community-onset pneumonia"},{"title3":"Quality of care, process, and outcomes in elderly patients with pneumonia"},{"title3":"Selective use of blood cultures in emergency department pneumonia patients"},{"title3":"Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals"},{"title3":"The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia: a prospective observational study"},{"title3":"The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures"},{"title3":"The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia"},{"title3":"Predicting bacteremia in patients with community-acquired pneumonia"},{"title3":"Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality"},{"title3":"Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia"},{"title3":"The routine use of urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment"},{"title3":"Vital signs: deficiencies in environmental control identified in outbreaks of legionnaires' disease. North America, 2000-2014"},{"title3":"Active bacterial core surveillance for legionellosis: United States, 2011-2013"},{"title3":"Preventing and controlling influenza with available interventions"},{"title3":"Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa"},{"title3":"Community-acquired pneumonia"},{"title3":"Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial"},{"title3":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections"},{"title3":"Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia"},{"title3":"Low procalcitonin, community acquired pneumonia, and antibiotic therapy"},{"title3":"A prediction rule to identify low-risk patients with community-acquired pneumonia"},{"title3":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study"},{"title3":"Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia"},{"title3":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia"},{"title3":"Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial"},{"title3":"Outpatient care compared with hospitalization for community-acquired pneumonia: a randomized trial in low-risk patients"},{"title3":"Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial"},{"title3":"The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia"},{"title3":"Improved management of community-acquired pneumonia in the emergency department"},{"title3":"Routine use of the Pneumonia Severity Index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: a multicenter, prospective, observational, controlled cohort study"},{"title3":"Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial"},{"title3":"Low-risk patients admitted with community-acquired pneumonia"},{"title3":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia"},{"title3":"Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial"},{"title3":"Treatment costs of community-acquired pneumonia in an employed population"},{"title3":"Clinical and economic burden of community-acquired pneumonia in the Medicare fee-for-service population"},{"title3":"CURB-65 pneumonia severity assessment adapted for electronic decision support"},{"title3":"Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission"},{"title3":"Validation and clinical implications of the IDSA/ATS minor criteria for severe community-acquired pneumonia"},{"title3":"Validation of the Infectious Diseases Society of America/American Thoracic Society minor criteria for intensive care unit admission in community-acquired pneumonia patients without major criteria or contraindications to intensive care unit care"},{"title3":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia"},{"title3":"Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia"},{"title3":"Prediction of severe community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Severity assessment tools to guide ICU admission in community-acquired pneumonia: systematic review and meta-analysis"},{"title3":"Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia"},{"title3":"The impact of a delay in intensive care unit admission for community-acquired pneumonia"},{"title3":"Outcomes of early, late, and no admission to the intensive care unit for patients hospitalized with community-acquired pneumonia"},{"title3":"Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality"},{"title3":"Antibiotics for community-acquired pneumonia in adolescent and adult outpatients"},{"title3":"Cethromycin versus clarithromycin for community-acquired pneumonia: comparative efficacy and safety outcomes from two double-blinded, randomized, parallel-group, multicenter, multinational noninferiority studies"},{"title3":"Efficacy and safety of moxifloxacin vs clarithromycin for community-acquired pneumonia"},{"title3":"A comparison of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study"},{"title3":"A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia"},{"title3":"Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia"},{"title3":"Clinical evaluation of telithromycin for community-acquired pneumonia phase III double-blind comparative study of telithromycin versus levofloxacin"},{"title3":"A randomized, double-blind, multicenter phase II study comparing the efficacy and safety of oral nemonoxacin with oral levofloxacin in the treatment of community-acquired pneumonia"},{"title3":"Comparison of clarithromycin and amoxicillin/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae"},{"title3":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults"},{"title3":"Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia"},{"title3":"Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia"},{"title3":"Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia"},{"title3":"Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia"},{"title3":"Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults"},{"title3":"Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia"},{"title3":"Treatment of community-acquired pneumonia in outpatients: randomized study of clarithromycin alone versus clarithromycin and cefuroxime"},{"title3":"Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis"},{"title3":"Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults"},{"title3":"Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults"},{"title3":"Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia"},{"title3":"Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae"},{"title3":"Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days"},{"title3":"Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia"},{"title3":"Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia"},{"title3":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae"},{"title3":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management"},{"title3":"Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults"},{"title3":"A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia"},{"title3":"High-dose levofloxacin in community-acquired pneumonia: a randomized, open-label study"},{"title3":"An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia"},{"title3":"Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors"},{"title3":"Antibiotic treatment strategies for community-acquired pneumonia in adults"},{"title3":"Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia"},{"title3":"Fluoroquinolones or macrolides alone versus combined with beta-lactams for adults with community-acquired pneumonia: systematic review and meta-analysis"},{"title3":"Antibiotic therapy for adults hospitalized with community-acquired pneumonia: a systematic review"},{"title3":"Omadacycline for community-acquired bacterial pneumonia"},{"title3":"beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial"},{"title3":"beta-Lactam/macrolide dual therapy versus beta-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis"},{"title3":"Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Efficacy and safety of iv-to-oral lefamulin, a pleuromutilin antibiotic, for treatment of community-acquired bacterial pneumonia: the phase 3 LEAP 1 trial"},{"title3":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Fluoroquinolones or macrolides in combination with beta-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Quantitative aspiration during sleep in normal subjects"},{"title3":"Aspiration pneumonitis and aspiration pneumonia"},{"title3":"Nursing home-acquired pneumonia: a case-control study"},{"title3":"A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia"},{"title3":"Treatment of aspiration pneumonia and primary lung abscess: penicillin G vs clindamycin"},{"title3":"Bacteriologic flora of aspiration-induced pulmonary infections"},{"title3":"Microbiology of severe aspiration pneumonia in institutionalized elderly"},{"title3":"The role of anaerobes in patients with ventilator-associated pneumonia and aspiration pneumonia: a prospective study"},{"title3":"Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures"},{"title3":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia"},{"title3":"Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia"},{"title3":"Health care-associated pneumonia in the intensive care unit: guideline-concordant antibiotics and outcomes"},{"title3":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia"},{"title3":"Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis"},{"title3":"Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home"},{"title3":"Healthcare-associated pneumonia: a US disease or relevant to the Asia Pacific, too?"},{"title3":"Adding fuel to the flames? It is time to leave HCAP"},{"title3":"Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia"},{"title3":"Trends in antibiotic use and nosocomial pathogens in hospitalized Veterans with pneumonia at 128 medical centers, 2006-2010"},{"title3":"Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia"},{"title3":"Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia"},{"title3":"Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model"},{"title3":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score"},{"title3":"Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis"},{"title3":"Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa"},{"title3":"Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia"},{"title3":"Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia"},{"title3":"Healthcare-associated pneumonia among hospitalized patients in a Korean tertiary hospital"},{"title3":"Prediction of methicillin-resistant Staphylococcus aureus in patients with non-nosocomial pneumonia"},{"title3":"Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia"},{"title3":"Patients presenting to the hospital with MRSA pneumonia: differentiating characteristics and outcomes with empiric treatment"},{"title3":"Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease"},{"title3":"Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients"},{"title3":"Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia"},{"title3":"The respiratory threat posed by multidrug resistant Gram-negative bacteria"},{"title3":"Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia"},{"title3":"A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia"},{"title3":"Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case-control study"},{"title3":"Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors"},{"title3":"Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens"},{"title3":"Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia"},{"title3":"Liver cirrhosis and diabetes mellitus are risk factors for Staphylococcus aureus infection in patients with healthcare-associated or hospital-acquired pneumonia"},{"title3":"Global initiative for methicillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study"},{"title3":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients"},{"title3":"De-escalation therapy among bacteraemic patients with community-acquired pneumonia"},{"title3":"Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia"},{"title3":"Effect of antibiotic streamlining on patient outcome in pneumococcal bacteraemia"},{"title3":"De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia"},{"title3":"Broad- versus narrow-spectrum oral antibiotic transition and outcomes in health care-associated pneumonia"},{"title3":"De-escalation as part of a global strategy of empiric antibiotherapy management: a retrospective study in a medico-surgical intensive care unit"},{"title3":"De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial"},{"title3":"Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis"},{"title3":"Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US Veterans Affairs Medical Centers"},{"title3":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society"},{"title3":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia"},{"title3":"The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications"},{"title3":"Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016"},{"title3":"Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study"},{"title3":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia"},{"title3":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial"},{"title3":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial"},{"title3":"Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update"},{"title3":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis"},{"title3":"Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data metaanalysis"},{"title3":"Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials"},{"title3":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial"},{"title3":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study"},{"title3":"Corticosteroids as adjunctive therapy in the treatment of influenza"},{"title3":"Outcomes of adults hospitalised with severe influenza"},{"title3":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada"},{"title3":"Fatalities associated with the 2009 H1N1 influenza A virus in New York city"},{"title3":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States"},{"title3":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09"},{"title3":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials"},{"title3":"Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an individual participant data metaanalysis"},{"title3":"Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza"},{"title3":"2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States"},{"title3":"Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season"},{"title3":"Invasive group A streptococcal infection concurrent with 2009 H1N1 influenza"},{"title3":"Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection"},{"title3":"Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis"},{"title3":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study"},{"title3":"Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study"},{"title3":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm"},{"title3":"Efficacite comparee de la ceftriaxone dans un traitement de dix jours versus un traitement raccourci de cinq jours des pneumonies aigues communautaires de l'adulte hospitalise avec facteur de risque [in French]"},{"title3":"Short- versus long-course antibacterial therapy for community-acquired pneumonia : a meta-analysis"},{"title3":"Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis"},{"title3":"Systematic review and meta-analysis of the efficacy of short-course antibiotic treatments for community-acquired pneumonia in adults"},{"title3":"Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ"},{"title3":"Procalcitonin for diagnosis of bacterial pneumonia in critically ill patients during 2009 H1N1 influenza pandemic: a prospective cohort study, systematic review and individual patient data meta-analysis"},{"title3":"Serum procalcitonin level, viral polymerase chain reaction analysis, and lower respiratory tract infection"},{"title3":"Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines"},{"title3":"Relationship between time to clinical response and outcomes among Pneumonia Outcomes Research Team (PORT) risk class III and IV hospitalized patients with community-acquired pneumonia who received ceftriaxone and azithromycin"},{"title3":"Predictors and implications of early clinical stability in patients hospitalized for moderately severe community-acquired pneumonia"},{"title3":"Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome"},{"title3":"Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients"},{"title3":"Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications"},{"title3":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial"},{"title3":"Is post-pneumonia chest X-ray for lung malignancy useful? Results of an audit of current practice"},{"title3":"Association of pneumonia and lung cancer: the value of convalescent chest radiography and follow-up"},{"title3":"Outcome of recommendations for radiographic follow-up of pneumonia on outpatient chest radiography"},{"title3":"Incidence, correlates, and chest radiographic yield of new lung cancer diagnosis in 3398 patients with pneumonia"},{"title3":"Diagnosis of pulmonary malignancy after hospitalization for pneumonia"},{"title3":"Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement"}]},{"title2":"Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance","References":[]},{"title2":"Clinical characteristics of coronavirus disease 2019 in China","References":[{"title3":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia."},{"title3":"Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2."},{"title3":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China."},{"title3":"First case of 2019 novel Coronavirus in the United States."},{"title3":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study."},{"title3":"A novel coronavirus associated with severe acute respiratory syndrome."},{"title3":"A preventive and control strategy for COVID-19 infection: an experience from a Third-Tier Chinese City."},{"title3":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies."},{"title3":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China."},{"title3":"Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2."},{"title3":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics."},{"title3":"Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia."},{"title3":"On the use of corticosteroids for 2019-nCoV pneumonia."},{"title3":"Comprehensive analysis of drugs to treat SARSCoV2 infection: mechanistic insights into current COVID19 therapies (Review)."},{"title3":"The role of telemedicine during the COVID-19 epidemic in China-experience from Shandong province."},{"title3":"Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial."},{"title3":"Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia."},{"title3":"Flattening the COVID-19 curve with natural killer cell based immunotherapies."},{"title3":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster."},{"title3":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event."},{"title3":"Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China."},{"title3":"Spatio-temporal metabolokinetics and efficacy of human placenta-derived mesenchymal stem/stromal cells on mice with refractory Crohn's-like enterocutaneous fistula."},{"title3":"High-efficient generation of VCAM-1(+) mesenchymal stem cells with multidimensional superiorities in signatures and efficacy on aplastic anaemia mice."},{"title3":"Systematic comparison of hUC-MSCs at various passages reveals the variations of signatures and therapeutic effect on acute graft-versus-host disease."},{"title3":"JNKi- and DAC-programmed mesenchymal stem/stromal cells from hESCs facilitate hematopoiesis and alleviate hind limb ischemia."},{"title3":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome."},{"title3":"Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review."},{"title3":"Three emerging coronaviruses in two decades."},{"title3":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future."},{"title3":"Coronaviruses - drug discovery and therapeutic options."},{"title3":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice."},{"title3":"Acute respiratory distress syndrome: the Berlin Definition."},{"title3":"Pediatric acute respiratory distress syndrome: definition, incidence, and epidemiology: proceedings from the Pediatric Acute Lung Injury Consensus Conference."},{"title3":"Eicosanoid storm in infection and inflammation."},{"title3":"Decoding the enigma of antiviral crisis: does one target molecule regulate all?"}]},{"title2":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","References":[]},{"title2":"Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection","References":[]},{"title2":"Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome?","References":[]},{"title2":"Pneumonia and pregnancy outcomes: a nationwide population-based study","References":[{"title3":"Pneumonia complicating pregnancy"},{"title3":"Pneumonia complicating pregnancy"},{"title3":"An appraisal of treatment guidelines for antepartum community- acquired pneumonia"},{"title3":"The effects of community-acquired pneumonia during pregnancy ending with a live birth"},{"title3":"Antepartum pneumonia in pregnancy"},{"title3":"Pneumonia during pregnancy"},{"title3":"Causes of maternal mortality in the United States"},{"title3":"Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy; American Thoracic Society; Medical Section of the American Lung Association"},{"title3":"Pneumonia in pregnancy"},{"title3":"Pneumonia complicating pregnancy"},{"title3":"Pneumonia in pregnancy"},{"title3":"Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome?"},{"title3":"Mechanical ventilation in an obstetric population: characteristics and delivery rates"},{"title3":"Risk factors associated with the increasing prevalence of pneumonia during pregnancy"},{"title3":"Pneumonia as a complication of pregnancy"},{"title3":"Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes"},{"title3":"The changing aspects of pneumonia complicating pregnancy"},{"title3":"Pneumonia in pregnancy"},{"title3":"Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States"},{"title3":"Pregnancy and perinatal outcomes of women with SARS"},{"title3":"Maternal acute respiratory infectious diseases during pregnancy and birth outcomes"},{"title3":"Acute and chronic respiratory diseases in pregnancy: associations with spontaneous premature rupture of membranes"},{"title3":"Risk of spontaneous preterm delivery in a low-risk population: the impact of maternal febrile episodes, urinary tract infection, pneumonia and ear-nose-throat infections"},{"title3":"Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women"},{"title3":"Intrauterine infection with varicella zoster virus after maternal varicella"},{"title3":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan"},{"title3":"Comorbidity profiles among patients with ankylosing spondylitis: a nationwide population-based study"},{"title3":"The functional activity of macrophages in mouse strains opposite in sensitivity to experimental tuberculosis"},{"title3":"New aspects of perinatal infections"},{"title3":"Prematurity: infection as an etiologic factor"},{"title3":"Infection in the pathogenesis of preterm labor"},{"title3":"Infection and labor, V: prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes"},{"title3":"Intrauterine infection and prematurity"},{"title3":"The preterm parturition syndrome"},{"title3":"Pulmonary ventilation in pregnancy"},{"title3":"Altitude, low birthweight, and infant mortality in Colorado"},{"title3":"Infant birthweight is related to maternal arterial oxygenation at high altitude"},{"title3":"Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women"},{"title3":"Pneumonia in pregnancy"}]},{"title2":"Management of first-trimester miscarriage: a systematic review and network meta-analysis","References":[]},{"title2":"Antibodies in infants born to mothers with COVID-19 pneumonia","References":[{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport"},{"title3":"Serum IgM in Diagnosis of Infection in the Newborn"},{"title3":"Antibodies in Infants Born to Mothers With COVID-19 Pneumonia"}]},{"title2":"Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn","References":[{"title3":"An assumed vertical transmission of SARS-CoV-2 during pregnancy: a case report and review of literature"},{"title3":"Lack of vertical transmission of severe acute respiratory syndrome coronavirus 2, China"},{"title3":"COVID-19 in a 26-week preterm neonate"},{"title3":"Unlikely SARS-CoV-2 vertical transmission from mother to child: a case report"},{"title3":"Risk factors associated with serious bacterial infections among newborns with high body temperature"},{"title3":"Detection of novel coronavirus (SARS-CoV-2) RNA in peripheral blood specimens"},{"title3":"Materno-fetal transmission of human coronaviruses: a prospective pilot study"},{"title3":"Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn"},{"title3":"Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure"},{"title3":"Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic"},{"title3":"Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises"},{"title3":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records"},{"title3":"Universal screening for SARS-CoV-2 in women admitted for delivery"},{"title3":"Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019"},{"title3":"Acute respiratory distress syndrome in a preterm pregnant patient with coronavirus disease 2019 (COVID-19)"},{"title3":"Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review"},{"title3":"Clinical characteristics of pregnant women with Covid-19 in Wuhan, China"},{"title3":"Detection of severe acute respiratory syndrome coronavirus 2 in placental and fetal membrane samples"}]}]}]}